𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen-independent expression of adrenomedullin and peptidylglycine α-amidating monooxygenase in human prostatic carcinoma

✍ Scribed by Nuria Jiménez; Ibane Abasolo; Johan Jongsma; Alfonso Calvo; Mercedes Garayoa; Theodorus H. van der Kwast; Gert J. van Steenbrugge; Luis M. Montuenga

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
488 KB
Volume
38
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Most of the locally advanced and metastatic prostate carcinomas (PCs) treated with antiandrogenic therapy eventually become refractory to this treatment. Locally produced factors may control prostate tumor biology after androgen withdrawal. Adrenomedullin (AM) is expressed in the prostate and could control cell growth in androgen‐independent conditions. AM needs to be amidated by the enzyme peptidylglycine α‐amidating monooxygenase (PAM) to become fully active. The objective of the present study was to analyze whether the expression of preproadrenomedullin (preproAM) and PAM in PC is regulated by androgens. For this purpose, human in vitro and in vivo PC models were grown in the presence or absence of androgens, and the expression of AM and PAM was examined by immunohistochemistry, Western blotting, RT‐PCR, and Northern blotting. Furthermore, immunohistochemical analysis of AM in clinical specimens was performed to test if its expression is related to Gleason score and antiandrogenic therapy. In PC cell lines and xenografts, mRNA and protein AM levels were similar in the presence or absence of androgens. PAM expression seemed to be induced by androgen‐withdrawal. Our results in clinical samples showed no relationship between AM expression and Gleason score or antiandrogenic treatment. In conclusion, our results demonstrate that preproAM and PAM expression in the human prostate is androgen‐independent. In addition, we also report for the first time the expression of a novel PAM transcript in PC, which has not been previously described in other tissues. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Expression and processing of peptidylgly
Expression and processing of peptidylglycine alpha-amidating monooxygenase messenger RNA in rat prostate
✍ Samos, Luis F.; Gkonos, Peter J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

The prostate gland contains neuroendocrine cells and amidated neuroendocrine peptides whose presence has been related to aggressive forms of prostate cancer. The enzyme peptidylglycine alpha-amidating monooxygenase (PAM) is critical to the biosynthesis of amidated peptides and is commonly present in

Peptidylglycine α-amidating monooxygenas
Peptidylglycine α-amidating monooxygenase- and proadrenomedullin-derived peptide–associated neuroendocrine differentiation are induced by androgen deprivation in the neoplastic prostate
✍ Nuria Jiménez; Johan Jongsma; Alfonso Calvo; Theodorus H. van der Kwast; Anthony 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB

Most PCs show NE differentiation. Several studies have tried to correlate NE expression with disease status, but the reported findings have been contradictory. Prostatic NE cells synthesize peptides with a wide spectrum of potential functions. Some of these active peptides, such as PAMP, are amidate

Aberrant expression of CARM1, a transcri
Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status
✍ Heng Hong; Chinghai Kao; Meei-Huey Jeng; John N. Eble; Michael O. Koch; Thomas A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

## Abstract ## BACKGROUND Coactivator‐associated arginine methyltransferase 1 (CARM1) is a transcriptional coactivator of the androgen receptor (AR). It is involved in the regulation of the biologic functions of the AR. It remains to be determined whether CARM1 is involved in prostatic carcinogene

Differential expression of 5α-reductase
Differential expression of 5α-reductase isoenzymes in the human prostate and prostatic carcinomas
✍ Bonkhoff, Helmut; Stein, Ute; Aumüller, Gerhard; Remberger, Klaus 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

BACKGROUND. Steroid 5a-reductase is essential for the intracellular accumulation of dihydrotestosterone (DHT), which mediates androgen effects on target tissue. METHODS. In the present study, we describe the differential expression and cellular localization of 5a-reductase 1 and 2 isoenzymes in the

Differential effects of naturally occurr
Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells
✍ John T. Pinto; Raghu Sinha; Kate Papp; Nicole D. Facompre; Dhimant Desai; Karam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 439 KB

## Abstract Epidemiological studies and clinical trials show that selenium supplementation results in reduction of prostate cancer incidence; however, the form of selenium and mechanisms underlying protection remain largely unknown. Toward this end, we compared the effects of naturally occurring se